Hadeel Mohammad
|
Selectivity of Protein Interactions Stimulated by Terahertz Signals
|
University of Toronto |
|
|
|
Elisabet Rodriguez Llorian
|
Application of Early Health Technology Assessments to Nanomedicine: A Review of Conceptual Frameworks
|
UBC |
Larry Lynd |
Core Facility |
eHTA: An early Health Technology Assessment platform
|
Sheldon Decombe
|
An ultrasensitive digital nanoassay for immunotherapy effectiveness
|
University of Toronto |
Aaron Wheeler |
Diagnostics |
An ultrasensitive digital nanoassay for immunotherapy effectiveness
|
Quinn Matthews
|
A platform for automated functionalization of lipid nanoparticles for CAR T cell therapy
|
University of Toronto |
Keith Pardee |
Diagnostics |
On-Demand Biofunctionalization of Lipid Nanoparticles for CAR T Cell Therapy
|
Michael Valic
|
Dose-dependencies in the plasma pharmacokinetics of a long-circulating porphyrin-lipid based nanoparticle
|
University of Toronto |
Gang Zheng |
Diagnostics |
|
Wanda Janaeska
|
A morphology-based classification algorithm for identifying caveolae, clathrin vesicles, and macropinosomes on electron microscopy images
|
University of Toronto |
Warren Chan |
Diagnostics |
|
Presley MacMillan
|
Liposome Imaging in Optically Cleared Tissues
|
University of Toronto |
Warren Chan |
Diagnostics |
|
Ariadne Tuckmantel Bido
|
Development of an LSPR-based SARS-CoV-2 Screening Test in Saliva
|
University of Victoria |
|
Diagnostics |
|
Irene Chen
|
The Development of an Impedance-Based Biosensor for Early Detection of Colon Cancer
|
University of Alberta |
David Wishart |
Diagnostics |
Nanoparticle-enhanced,impedance-based biosensor development for cancer diagnostics
|
Nashmia Zia
|
Early Detection is Key: Nanomicelles for Timely Diagnosis of Liver Fibrosis
|
University of Toronto |
Gilbert Walker |
Diagnostics |
|
Miffy Cheng
|
Stable J-aggregation of an aza- BODIPY-lipid in a liposome for optical cancer imaging
|
Princess Margret Cancer Centre |
Gang Zheng |
Diagnostics |
|
Payton LeBlanc
|
Nanoparticle Enhanced, Impedance-Based Biosensor Development for Cancer Diagnosis
|
University of Alberta |
David Wishart |
Diagnostics |
Nanoparticle-enhanced, impedance-based biosensor development for cancer diagnostics
|
Johnny Zhang
|
An analysis of the function and structure of the protein corona on nanoparticles
|
University of Toronto |
Warren Chan |
Diagnostics |
Predicting nanoparticle tumour delivery via serum protein adsorption
|
Wesley Walker
|
Bacteriopheophorbide nanoemulsions as photodynamic therapy agents
|
University of Toronto |
Gang Zheng |
Diagnostics |
|
Bill Duong
|
Development of a microfluidic chip for exosomal PD-L1 analysis in lung cancer
|
University of Toronto |
Shana Kelley |
Diagnostics |
Development of an integrated chip for exosome analysis in cancer
|
Cécile Darviot
|
Cytopathology diagnostic with multiplexed plasmonic biomarkers
|
École Polytechnique de Montréal |
Michel Meunier |
Diagnostics |
|
Jennyfer Zapata-Farfan
|
Non-invasive cornea nanosurgery using plasmonic nanoparticles and femtosecond laser
|
Polytechnique Montréal |
Michel Meunier |
Gene Therapy |
|
Cameron Hastie
|
Non-equilibrium Structural Dynamics of Supercoiled DNA Plasmids
|
UBC |
Sabrina Leslie |
Gene Therapy |
|
Madelaine Robertson
|
RNA: The Key to Improving Platelet Transfusions?
|
UBC |
Pieter Cullis, Christian Kastrup |
Gene Therapy |
|
Sarah Thomson
|
Development of lipid nanoparticle-enabled gene therapy approaches in the brain
|
UBC |
Blair Leavitt |
Gene Therapy |
Development and optimization of LNP-based gene therapy approaches in the brain
|
Juliana Bolsoni
|
Topical delivery of gene-editing tools into human skin
|
UBC |
Sarah Hedtrich |
Gene Therapy |
|
Albert Kamanzi
|
Single-particle microscopy of lipid nanoparticles and applications to vaccines and genetic medicines
|
UBC |
Sabrina Leslie |
Gene Therapy |
Single-particle measurements to enable rational design of lipid nanoparticle carriers for gene therapies and vaccines
|
Tyler Thomson
|
Development of a luciferase reporter mouse model for adenine base editing
|
UBC |
Colin Ross |
Gene Therapy |
|
Anthony Tam
|
Identifying lipid nanoparticle formulations for nasal RNA delivery targeting the murine respiratory mucosa
|
UBC |
James Lim |
Gene Therapy |
|
Kent Chen
|
The Metaplex Technology: A solution to the development of poorly soluble metal-binding small molecules
|
Cuprous Pharmaceuticals |
Marcel Bally |
Targeted Drug Delivery |
Development of the Metaplex immuno-oncology platform
|
Forugh Sanaee
|
Pharmacokinetics of Nano versus Conventional Formulations of A83B4C63, a Novel Inhibitor of DNA Repair in Rat
|
University of Toronto |
Afsaneh Lavasanifar |
Targeted Drug Delivery |
Nano-delivery of novel inhibitors of DNA repair for enhanced therapy in head & neck cancer
|
Noorjahan Aibani
|
Design and in-vivo evaluation of lipid nanoparticles with a triple adjuvant to achieve enhanced immunity against Bordetella pertussis
|
University of Saskatchewan |
Ellen Wasan |
Targeted Drug Delivery |
Lipidic nanoparticle formulation of a triple adjuvant for intra-nasal vaccines for pertussis and influenza
|
Po-Han Chao
|
Liposomal Resiquimod for Enhanced Immunotherapy of Peritoneal Metastases of Colorectal Cancer
|
UBC |
Star Li |
Targeted Drug Delivery |
|
Tiffany Ho
|
Enhancing porphyrin intracellular delivery with next-generation porphysomes for photodynamic therapy
|
University of Toronto |
Gang Zheng |
Targeted Drug Delivery |
|
Courtney van Ballegooie
|
X-Ray Triggered Drug Release of Hybrid Protein-Gold Nanoparticle
|
UBC |
|
Targeted Drug Delivery |
|
Talita de Francesco
|
Gold Nanoparticles Encapsulation into Polymeric Micelles for Cancer Theranostics
|
University of Victoria |
|
Targeted Drug Delivery |
|
Yifei Gu
|
Single-Particle Measurements of Size and Loading for Drug-delivery Lipid Nanoparticles
|
UBC |
Sabrina Leslie |
Targeted Drug Delivery |
|
Fariba Saadati
|
Novel Sulfur-Containing Lipids for the Delivery of RNA Therapeutics
|
UBC |
Marco Ciufolini |
Targeted Drug Delivery |
Synthesis and Evaluation of Novel Sulfur-Containing Lipids
|
Lucy Wang
|
PARP Inhibitor Drug Combinations and the Six Rights
|
University of Toronto |
Christine Allen |
Targeted Drug Delivery |
|
Abdulaziz (Zé) Alhussan
|
Synergetic Combined Modality of Nanotechnology, Chemotherapy, and Radiotherapy for the Treatment of Pancreatic Cancer
|
University of Victoria |
Devika Chithrani |
Targeted Drug Delivery |
|
Parnian Mehinrad
|
Repurposing Pyronaridine as a novel inhibitor of heterodimeric ERCC1-XPF DNA endonuclease for targeted sensitization of colorectal cancer to platinum-based chemotherapeutics
|
University of Alberta |
Afsaneh Lavasanifar |
Targeted Drug Delivery |
|
Colton Strong
|
Optimized Lipid Nanoparticles Enable Exogenous Protein Production in Platelets
|
UBC |
Christian Kastrup |
Targeted Drug Delivery |
|
Alberto Cevallos
|
Characterization of Y-Nanotexaphyrin for Applications in Cancer Therapy
|
University of Toronto |
Gang Zheng |
Targeted Drug Delivery |
|
Nasim Sarrami
|
Panitumumab modified polymer-based nano-theranostics for non-small cell lung cancer imaging and therapy
|
University of Alberta |
Afsaneh Lavasanifar |
Targeted Drug Delivery |
|
Yulin Mo
|
Light-Activated siRNA Endosomal Release (LASER) by Porphyrin Lipid Nanoparticles
|
University of Toronto |
Gang Zheng |
Targeted Drug Delivery |
|
Amélie Baron
|
EPlasmonic enhanced femtosecond laser anticancer drug delivery using gold-lipid nanoparticles
|
Polytechnique Montréal |
Michel Meunier |
Targeted Drug Delivery |
|
Nolan Jackson
|
Utilization of nanotechnology and chemotherapeutics to increase radiosensitivity of cancer cells
|
University of Victoria |
Devika Chithrani |
Targeted drug Delivery |
|
Abdulaziz (Zé) Alhussan
|
An Integrated Approach Utilizing Nanotechnology, Chemotherapy, and Radiotherapy for Pancreatic Cancer Treatment
|
University of Victoria |
Devika Chithrani |
Targeted Drug Delivery |
|
Vanessa Chan
|
Liposomal Resiquimod for Treatment of Colorectal Cancer Metastasis
|
UBC |
Star Li |
Targeted Drug Delivery |
|
Liza Silverman
|
Microfluidic Co-encapsulation of Curcumin with SN-38 in PCL-block-PEO Polymer Nanoparticles
|
University of Victoria |
Matthew Moffit |
Targeted Drug Delivery |
|